Jun 24
|
Green Hydrogen: A viable future for UK’s renewable energy?
|
Jun 24
|
Boston Scientific secures CE mark for Deep Brain Stimulation software
|
Jun 24
|
In data: South Korea, Singapore ‘most willing’ to pay for sustainable fashion
|
Jun 24
|
Insulet plans label expansion for Omnipod in type 2 diabetes
|
Jun 24
|
The evolution of contract packagers: delivering sustainability for injectables packaging
|
Jun 24
|
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion
|
Jun 21
|
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
|
Jun 21
|
Sarepta’s Elevidys secures US label expansion for DMD
|
Jun 21
|
China hydro production peaks, reducing coal reliance
|
Jun 21
|
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
|
Jun 21
|
How automation and robotics help solve industrial maintenance challenges
|
Jun 21
|
Study finds rewarding AI can expand access to stroke care
|
Jun 21
|
In data: Energy drinks forecast to outpace rival US categories
|
Jun 21
|
South Korea seeks to accelerate drug reimbursement administration process
|
Jun 21
|
Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet needs
|
Jun 21
|
Gay and bisexual men have higher risk of anxiety and depression
|
Jun 21
|
Microbot partners with Boston Hospital to trial Liberty surgical robot
|
May 10
|
Lincoln future, Delphi injection, BMW AV – the week
|
May 10
|
38% of companies lack an ESG strategy – GlobalData survey
|
May 10
|
UK beer sales “just starting to recover” from Covid volume slump – GlobalData
|